Supply Issues Becton Dickinson (Distributed by Embecta UK Ltd) Insulin Needle and Syringe FWD083 (ICN 2530)

Change:

• The distributor Embecta UK Ltd has informed us of a supply issue with Becton Dickinson Insulin Needle and Syringe products, FWD083.
• The supply issue is due to raw material shortage.
• We are currently exploring with the supplier if any other products within the range are impacted and will update this ICN once we have further information.

Impact:

• FWD083 is available whilst current stock lasts, once the stock is depleted the product code will be unavailable until we receive further deliveries.
• Potential indirect alternative products are available to order through our online catalogue:
  • FWD326 – Insulin Needle and Syringe 30G x 8mm needle with 1ml Syringe Sterile
  • FSW1324 – Insulin Needle and Syringe 30G x 8mm (0.315 inch) Integrated Needle with 1ml Luer Lock Concentric Syringe Clear Plunger Sterile
  • FWD351 – Insulin Needle and Syringe 30G x 8mm (0.315 inch) Integrated Needle with 1ml Luer Lock Concentric Syringe Sterile.
• The following safety alternatives are also available:
• • FTR1279 – Safety Insulin Needle & Syringe 30G Lavender x 8mm with 1ml Luer Lock 3 Piece Eccentric Syringe Sterile
  • FTR2200 – Safety Insulin Needle & Syringe 30G x 8mm with 1ml u-100 Syringe with fixed needle
  • FWD85003 – Safety Insulin Needle & Syringe 30G x 8mm (0.3125 inch) Fixed Retractable Needle with 1ml Insulin Syringe.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives including the safety alternatives.
• The supply issue is anticipated to be resolved by 1 July 2024.  

Next Steps:              

• Customers are advised to log into our website to view the product listing for further information on the affected product code and potential alternatives.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products. we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.